NIR Arthroscopic Fluorescence Angiography of Menisci (FLUORarth)
Primary Purpose
Meniscus Rupture
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
NIR fluorescence imaging of the vascular perfusion of the meniscus using ICG
Sponsored by
About this trial
This is an interventional treatment trial for Meniscus Rupture
Eligibility Criteria
Inclusion Criteria:
- 18 years or older;
- Patients with on MRI confirmed Zone 1 meniscal tear
- Patients with a clinical indication for arthroscopic meniscal repair
- Before patient registration, written consent must be given according to ICH/GCP, national and local regulations.
Exclusion Criteria:
- Prior operative treatment of the ruptured meniscus
- Any condition that in the opinion of the investigator could potentially jeopardize the health status of the patient. In specific, these conditions concern smoking, diabetes and being overweight.
- Pregnancy
- allergy to iodine, shellfish or ICG;
- Psychological, familial sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial;
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
NIR fluorescence
Arm Description
The included patients will be subdivided in four equal subgroups in order to evaluate alteration of NIR fluorescence signal during arthroscopy in combination with a (temporary) tourniquet and irrigation pump system.
Outcomes
Primary Outcome Measures
NIR fluorescence of the meniscus
Detection of fluorescence in the meniscus (yes/no), determined intra-operatively during the arthroscopy procedure using NIR fluorescence imaging and ICG.
Secondary Outcome Measures
T start
Time between injection of ICG and initial detection of the fluorescence signal in the meniscus (T start).
I max
Maximum fluorescence intensity (Imax) in the meniscus. Fluorescence intensity will be measured in arbitrary units as a mean of three different region of interests.
T max
Time to maximum intensity of the fluorescence signal
Baseline and End fluorescence intensity
Baseline fluorescence intensity of the meniscus and the end fluorescence intensity in the meniscus
The ration between the maximum fluorescence intensity in the meniscus and the background fluorecence intensity.
The fluorescence intensity is measured in arbitrary units as a mean of three region of interests.
Full Information
NCT ID
NCT05420974
First Posted
June 7, 2022
Last Updated
June 11, 2022
Sponsor
Isala
Collaborators
Arthrex, Inc., Diagnostic Green GmbH
1. Study Identification
Unique Protocol Identification Number
NCT05420974
Brief Title
NIR Arthroscopic Fluorescence Angiography of Menisci
Acronym
FLUORarth
Official Title
Intraoperative Arthroscopic Near-infrared Fluorescence Imaging of the Vascular Perfusion of the Meniscus in Patients Treated With Meniscal Repair
Study Type
Interventional
2. Study Status
Record Verification Date
June 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
September 1, 2022 (Anticipated)
Primary Completion Date
August 31, 2023 (Anticipated)
Study Completion Date
October 31, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Isala
Collaborators
Arthrex, Inc., Diagnostic Green GmbH
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This trial is an explorative single center, single-arm study to assess whether vascularization of the meniscus can be visualized intraoperatively using arthroscopic near-infrared (NIR) fluorescence using ICG during standard of care meniscal repair treatment.
Detailed Description
The meniscal healing process is based on two fundamental principles: a solid primary fixation, and a well-functioning biological process of cicatrization, where the presence of vascularization is thought to play a major role. Intra-operative near infrared fluorescence angiography using Indocyanine Green (ICG) is a widely used method for operative assessment of vascularization. Fluorescence guided detection of the vascularity surrounding a meniscal tear could be of great value to predict meniscal healing after repair.
This pilot study will explore the technical feasibility of intraoperative near-infrared fluorescence angiography of the meniscus in patients undergoing arthroscopic meniscal repair. Technical challenges for NIR fluorescence arthroscopy are the visibility of the vascular perfusion in microvessels in the dense meniscus, motion artifacts encountered with arthroscopy and wash in of ICG using a fluid irrigation system.
The included patients will be subdivided in four equal subgroups in order to evaluate alteration of NIR fluorescence signal during arthroscopy in combination with a tourniquet and/or irrigation pump system.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Meniscus Rupture
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
NIR fluorescence
Arm Type
Experimental
Arm Description
The included patients will be subdivided in four equal subgroups in order to evaluate alteration of NIR fluorescence signal during arthroscopy in combination with a (temporary) tourniquet and irrigation pump system.
Intervention Type
Procedure
Intervention Name(s)
NIR fluorescence imaging of the vascular perfusion of the meniscus using ICG
Intervention Description
NIR fluorescence imaging of vascular perfusion using the Arthrex NIR fluorescence scope and Indocyanin Green
Primary Outcome Measure Information:
Title
NIR fluorescence of the meniscus
Description
Detection of fluorescence in the meniscus (yes/no), determined intra-operatively during the arthroscopy procedure using NIR fluorescence imaging and ICG.
Time Frame
Fluorescence imaging will be performed from 0-10 minutes after injection of ICG
Secondary Outcome Measure Information:
Title
T start
Description
Time between injection of ICG and initial detection of the fluorescence signal in the meniscus (T start).
Time Frame
Fluorescence imaging will be performed from 0-10 minutes after injection of ICG
Title
I max
Description
Maximum fluorescence intensity (Imax) in the meniscus. Fluorescence intensity will be measured in arbitrary units as a mean of three different region of interests.
Time Frame
Fluorescence imaging will be performed from 0-10 minutes after injection of ICG
Title
T max
Description
Time to maximum intensity of the fluorescence signal
Time Frame
0-10 minutes
Title
Baseline and End fluorescence intensity
Description
Baseline fluorescence intensity of the meniscus and the end fluorescence intensity in the meniscus
Time Frame
Fluorescence imaging will be performed from 0-10 minutes after injection of ICG
Title
The ration between the maximum fluorescence intensity in the meniscus and the background fluorecence intensity.
Description
The fluorescence intensity is measured in arbitrary units as a mean of three region of interests.
Time Frame
Fluorescence imaging will be performed from 0-10 minutes after injection of ICG
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
18 years or older;
Patients with on MRI confirmed Zone 1 meniscal tear
Patients with a clinical indication for arthroscopic meniscal repair
Before patient registration, written consent must be given according to ICH/GCP, national and local regulations.
Exclusion Criteria:
Prior operative treatment of the ruptured meniscus
Any condition that in the opinion of the investigator could potentially jeopardize the health status of the patient. In specific, these conditions concern smoking, diabetes and being overweight.
Pregnancy
allergy to iodine, shellfish or ICG;
Psychological, familial sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial;
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Pieter B.A.A. van Driel, MD, PhD
Phone
003188 6245000
Email
p.b.a.a.van.driel@isala.nl
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
23881033
Citation
Vahrmeijer AL, Hutteman M, van der Vorst JR, van de Velde CJ, Frangioni JV. Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol. 2013 Sep;10(9):507-18. doi: 10.1038/nrclinonc.2013.123. Epub 2013 Jul 23.
Results Reference
result
PubMed Identifier
34064948
Citation
Goncalves LN, van den Hoven P, van Schaik J, Leeuwenburgh L, Hendricks CHF, Verduijn PS, van der Bogt KEA, van Rijswijk CSP, Schepers A, Vahrmeijer AL, Hamming JF, van der Vorst JR. Perfusion Parameters in Near-Infrared Fluorescence Imaging with Indocyanine Green: A Systematic Review of the Literature. Life (Basel). 2021 May 11;11(5):433. doi: 10.3390/life11050433.
Results Reference
result
PubMed Identifier
34347140
Citation
van Schie P, van der Lelij TJN, Gerritsen M, Meijer RPJ, van Arkel ERA, Fiocco M, Swen JA, Vahrmeijer AL, Hazelbag HM, Keereweer S, van Driel PBAA. Intra-operative assessment of the vascularisation of a cross section of the meniscus using near-infrared fluorescence imaging. Knee Surg Sports Traumatol Arthrosc. 2022 May;30(5):1629-1638. doi: 10.1007/s00167-021-06690-w. Epub 2021 Aug 4.
Results Reference
result
Learn more about this trial
NIR Arthroscopic Fluorescence Angiography of Menisci
We'll reach out to this number within 24 hrs